Alzheimer, xenon gas

This Anesthesia Gas Could Be the Next Big Alzheimer’s Treatment
The next Alzheimer’s treatment could come from an unexpected place. In new research released this week, scientists have found evidence in mice that xenon gas might be able to help treat the neurodegenerative condition.
A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ability to mitigate brain damage and improve cognitive functions in mouse models.
Could inhaling xenon gas help treat Alzheimer’s? A new mouse study suggests it might
The gas xenon, like the other noble, or inert, gases, is known for doing very little. The class of elements, because of its molecular structure, don’t typically interact with many chemicals.
Mountain climbing and treating Alzheimer's: Could xenon gas have potential?
In a trial featuring a mouse model of Alzheimer's, scientists found that inhaling a mixture containing xenon gas helped reduce levels of brain atrophy and neuroinflammation.
‘Novel approach’ to treating Alzheimer’s disease discovered — it’s a gas
Alzheimer’s is the most common form of dementia — it causes memory loss, confusion, thinking problems and behavioral changes.
Xenon gas could protect against Alzheimer's disease: Mouse study
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that accumulate in the brain, but new research points to a novel -- and noble -- approach: using Xenon gas.
Tackling Everest in a Week is Now Made Possible with the use of Xenon Gas
Recently, the Financial Times released an article featuring a climbing company whose goal is to offer their clients the use ...
You Can Now Climb Everest in a Week Using Xenon Gas: The Implications
This spring, a group of commercial climbers plan to summit Everest in just a week by chemically boosting their ...
TipRanks on MSN2d
Xenon Pharmaceuticals’ CCO Departure and Consultancy Role
Christopher Von Seggern stepped down as Chief Commercial Officer of Xenon Pharmaceuticals Inc. and departed from the company. In connection with his departure ...
ALZFORUM2d
Inhaled Xenon for AD?
Butovsky believes xenon has potential as an AD treatment. A Phase 1 clinical trial of xenon at BWH is recruiting healthy elderly volunteers to test safety and effects on immune cells. “I hope this ...
Xenon gas offers potential neuroprotective effects for Alzheimer's patients
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...
Xenon Pharmaceuticals announces executive changes
Xenon Pharmaceuticals Inc. (NASDAQ:XENE), a $3 billion market cap pharmaceutical company specializing in the development of therapeutic drugs, announced today the departure of its Chief Commercial ...
Assenagon Asset Management S.A. Purchases 26,235 Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE)
Assenagon Asset Management S.A. raised its position in Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) by 12.4% during the 4th quarter, HoldingsChannel reports. The fund owned 238,522 shares of ...
STAT2d
The biotech news stories we’re keeping an eye on
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.